AKLIEF: payments to doctors
Payments that named AKLIEF as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7.7M
- Providers
- 11,118
- Transactions
- 69,173
- Average per transaction
- $112
The per-transaction average — $112 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,118 providers the average total is $696, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Galderma Laboratories, L.p. | $7,728,572 | 99.9% |
| Galderma Research & Development, LLC | $10,700 | 0.1% |